Amber Bio

About Amber Bio

Amber Bio is a biotechnology company focused on pioneering new gene editing modalities with multi-kilobase edits to target previously undruggable patient populations. Founded by CRISPR field pioneers, the company is developing a unique RNA writing platform to edit thousands of mutations with a single product, aiming for safe, precise, and affordable gene therapies.

Products & Services

RNA Writing Platform:A first-of-its-kind platform for editing thousands of diverse mutations across patients with a single product, focusing on multi-kilobase RNA edits.

Specialties

Gene Editing RNA Writing Multi-Kilobase Edits Genetic Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series Seed T: - FT: Series Seed	A: 26000000 MR: - FA: $26M FAN: 26000000	D: 2023-08-24 FD: 2023-08-24	6 investors
2	RT: Seed T: - FT: Seed	A: 26000000 MR: - FA: $26 Million FAN: 26000000	D: 2023-08-03 FD: 2023-08-03	6 investors

Series Seed Latest

2023-08-24

$26.0M

6 investors (Pro only)

Seed 2023-08-03

$26.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Awilda Rosario

Principal Bioarchitect

C

Changchang Liu

Biodesigner I

D

Daniel Richards

Bioarchitect II

D

David Schaffer, PhD

SAB

D

David Yao, PhD

Bioarchitect III

F

Federico Mingozzi, PhD

SAB

View 38 more team members with Pro

Unlock Full Team Directory

Recent News

Amber Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised